Steroid-induced fibroblast growth factors drive an epithelial-mesenchymal inflammatory axis in severe asthma
- 20 April 2022
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 14 (641) , eabl8146
Abstract
Asthma and inflammatory airway diseases restrict airflow in the lung, compromising gas exchange and lung function. Inhaled corticosteroids (ICSs) can reduce inflammation, control symptoms, and improve lung function; however, a growing number of patients with severe asthma do not benefit from ICS. Using bronchial airway epithelial brushings from patients with severe asthma or primary human cells, we delineated a corticosteroid-driven fibroblast growth factor (FGF)–dependent inflammatory axis, with FGF-responsive fibroblasts promoting downstream granulocyte colony-stimulating factor (G-CSF) production, hyaluronan secretion, and neutrophilic inflammation. Allergen challenge studies in mice demonstrate that the ICS, fluticasone propionate, inhibited type 2–driven eosinophilia but induced a concomitant increase in FGFs, G-CSF, hyaluronan, and neutrophil infiltration. We developed a model of steroid-induced neutrophilic inflammation mediated, in part, by induction of an FGF-dependent epithelial-mesenchymal axis, which may explain why some individuals do not benefit from ICS. In further proof-of-concept experiments, we found that combination therapy with pan-FGF receptor inhibitors and corticosteroids prevented both eosinophilic and steroid-induced neutrophilic inflammation. Together, these results establish FGFs as therapeutic targets for severe asthma patients who do not benefit from ICS.Keywords
This publication has 138 references indexed in Scilit:
- Corticosteroid‐induced gene expression in allergen‐challenged asthmatic subjects taking inhaled budesonideBritish Journal of Pharmacology, 2012
- Hyaluronan deposition and correlation with inflammation in a murine ovalbumin model of asthmaMatrix Biology, 2011
- Allergen-Induced Coexpression of bFGF and TGF-β1 by Macrophages in a Mouse Model of Airway Remodeling: bFGF Induces Macrophage TGF-β1 Expression in vitroInternational Archives of Allergy and Immunology, 2010
- T-helper Type 2–driven Inflammation Defines Major Subphenotypes of AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 2009
- FGF9-induced proliferative response to eosinophilic inflammation in oesophagitisGut, 2008
- Respiratory syncytial virus infection provokes airway remodelling in allergen‐exposed mice in absence of prior allergen sensitizationClinical & Experimental Allergy, 2008
- Regulation of growth factor signaling by FRS2 family docking/scaffold adaptor proteinsCancer Science, 2008
- Natural glucocorticoids induce expansion of all developmental stages of murine bone marrow granulocytes without inhibiting functionProceedings of the National Academy of Sciences, 2008
- Endogenous glucocorticoids control neutrophil mobilization from bone marrow to blood and tissues in non‐inflammatory conditionsBritish Journal of Pharmacology, 2007
- Genome-wide profiling identifies epithelial cell genes associated with asthma and with treatment response to corticosteroidsProceedings of the National Academy of Sciences, 2007